Transpharmation Ltd. is a preclinical CRO spun out of GlaxoSmithKline in 2010. Building on the international reputation and CNS drug discovery expertise of the founders, the company has enjoyed unprecedented growth since inception and is a forerunner in ‘bench-to-bedside’ translational pharmacology. Read More
Vidrio Technologies was spun out of the Howard Hughes Medical Institute in 2013 to commercialize two-photon laser-scanning microscopy (TPLSM) software, hardware, and imaging services. The company’s primary products are the software package ScanImage® and control electronics that interfaces with microscopes. Vidrio’s software optimizes imaging for a new 5mm field of view TPLSM that allows half of a functioning mouse brain to be imaged with cellular resolution. Large-scale electrophysiology analysis software is also a Vidrio product.
PsychoGenics, a leading provider of preclinical CNS capabilities offers behavioral testing, electrophysiology, EEG, histology and microdialysis, along with a variety of transgenic mouse models for dozens of neurodegenerative and psychiatric disorders. PsychoGenics has also pioneered the translation of rodent behavioral responses into robust, high-throughput, high content phenotyping and drug discovery… Read More